What Is the Optimal Bridging Therapy for Patients with Hepatitis C-associated Hepatocellular Carcinoma Awaiting Liver Transplant? An Analysis of the United States HCC Liver Transplantation Consortium.
Saved in:
| Title: | What Is the Optimal Bridging Therapy for Patients with Hepatitis C-associated Hepatocellular Carcinoma Awaiting Liver Transplant? An Analysis of the United States HCC Liver Transplantation Consortium. |
|---|---|
| Authors: | Medin, C.1 (AUTHOR), Turgeon, M.1 (AUTHOR), Keilson, J.1 (AUTHOR), Shah, S.2 (AUTHOR), Agopian, V.3 (AUTHOR), Magliocca, J.1 (AUTHOR), Cameron, A.4 (AUTHOR), Orloff, S.5 (AUTHOR), Kubal, C.6 (AUTHOR), Cannon, R.7 (AUTHOR), Akoad, M.8 (AUTHOR), Emamaullee, J.9 (AUTHOR), Aucejo, F.10 (AUTHOR), Vagefi, P.11 (AUTHOR), Nguyen, M.12 (AUTHOR), Dhanireddy, K.13 (AUTHOR), Kazimi, M.14 (AUTHOR), Sonnenday, C.15 (AUTHOR), Foley, D.16 (AUTHOR), Abouljoud, M.17 (AUTHOR) |
| Source: | HPB (1365-182X). 2022 Supplement1, Vol. 24, pS78-S78. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 1365182X |
|---|---|
| DOI: | 10.1016/j.hpb.2022.05.142 |
